A novel assay to measure calcification propensity: from laboratory to humans

Cardiovascular calcification (CVC) contributes to morbidity and mortality in patients undergoing dialysis. We examined the pharmacodynamic effects of SNF472, a calcification inhibitor, on plasma calcium phosphate crystallization using spectrometric measurements, and its correlations with effects on...

Descripción completa

Detalles Bibliográficos
Autores principales: Perez, M. Mar, Ferrer, Miguel D., Lazo-Rodriguez, Marta, Canals, Ana Zeralda, Banon-Maneus, Elisenda, Campistol, Josep M., Miller, Stephan, Garg, Rekha, Gold, Alex, Salcedo, Carolina, Perelló, Joan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568551/
https://www.ncbi.nlm.nih.gov/pubmed/33067536
http://dx.doi.org/10.1038/s41598-020-74592-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7568551/
https://www.ncbi.nlm.nih.gov/pubmed/33067536
http://dx.doi.org/10.1038/s41598-020-74592-x

Ejemplares similares